FDA Drug Safety Communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal hea
This is a discussion on FDA Drug Safety Communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal hea within the FDA News forum, part of the Industry News and Updates category; The U.S. Food and Drug Administration (FDA) is reviewing clinical trial data about a potentially serious effect on the ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
02-23-2010, 11:59 AM
|
|||
|
|||
FDA Drug Safety Communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal hea
The U.S. Food and Drug Administration (FDA) is reviewing clinical trial data about a potentially serious effect on the heart from the use of Invirase (saquinavir) in combination with Norvir (ritonavir).
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Early Communication about an Ongoing Safety Review of*Meridia (sibutramine hydrochloride) | industry_news | FDA News | 0 | 11-20-2009 07:59 PM |
| Early Communication about an Ongoing Safety Review of*Deferasirox (marketed as Exjade) | industry_news | FDA News | 0 | 09-25-2009 02:59 PM |
| FDA updates the Early Communication about the Ongoing Safety Review of Bisphosphonates | industry_news | FDA News | 0 | 11-12-2008 10:48 AM |
| Epoetin alfa - Early Communication about an Ongoing Safety Review | industry_news | FDA News | 0 | 09-26-2008 11:42 AM |
| FDA issues an Early Communication about an Ongoing Safety Review for Botox | industry_news | FDA News | 0 | 02-26-2008 02:30 PM |
© 2008 DrugManagementForum™ powered by |
 |